Mesoridazine

In the US, Mesoridazine (mesoridazine systemic) is a member of the drug class phenothiazine antipsychotics and is used to treat Schizophrenia.

US matches:

• Mesoridazine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AC03

CAS registry number (Chemical Abstracts Service)

0005588-33-0

Chemical Formula

C21-H26-N2-O-S2

Molecular Weight

386

Therapeutic Category

Neuroleptic

Chemical Name

10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)-

Foreign Names

• Mesoridazinum (Latin)
• Mesoridazin (German)
• Mésoridazine (French)
• Mesoridazina (Spanish)

Generic Names

• Mesoridazine (OS: BAN, USAN)
• Mésoridazine (OS: DCF)
• NC 123 (IS)
• TPS 23 (IS)
• Mesoridazine methylsulfonate (IS)

Brand Name

• Lidanil
  Novartis, Turkey

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.